One biological foundation.
Two proprietary platforms.
BETTER MEDICINES.
Titanium Microneedle Platform
Precision Drug Delivery to the Dermis
THE PLATFORM
A proprietary titanium microneedle platform engineered to deliver a broad range of medicines rapidly and precisely through the dermis.
WHAT MAKES IT DIFFERENT
Ultra-fine titanium microneedles bypass the gastrointestinal tract and conventional injections, enabling fast, reliable drug delivery through the skin.
WHY IT MATTERS
The platform unlocks new possibilities for therapies where speed, patient convenience, and consistent systemic delivery are critical.
WHAT IT STANDS TODAY
The platform is designed to support future applications across multiple therapeutic indications.
GOLD NANOPARTICLE Platform
Programming immune recognition through the dermis.
Programmable gold nanoparticles coated with biocompatible sugars and loaded with disease-specific peptide antigens.
THE PLATFORM
A programmable gold nanoparticle platform designed to teach the immune system to recognize and attack specific targets — tumor cells or pathogens.
WHAT MAKES IT DIFFERENT
Delivered into the dermis — the body’s most antigen presenting cell (APC)-rich tissue — creating precise, durable immune responses.
WHY IT MATTERS
Oncology: tumor & viral antigen targeting, combination immunotherapy. Infectious disease: vaccines for viruses. Human clinical data in hand.
WHERE IT STANDS TODAY
Preclinical oncology studies planned. Multiple infectious disease trials active or approved. GMP manufacturing in Oxford. US IND, UK CTA in place.